期刊文献+

高敏肌钙蛋白I低水平表达在冠心病中的诊断价值 被引量:6

暂未订购
导出
摘要 目的探讨高敏肌钙蛋白I(hs-cTnI)低水平表达的胸痛患者冠状动脉造影情况,了解hs-cTnI的低水平表达在冠心病诊断中的价值。方法选择hs-cTnI水平为0.006~0.04ng/mL的胸痛患者,根据冠脉造影结果分为冠心病组与非冠心病组,比较两组的hs-cTnI水平及其与冠状动脉Gensini积分的相关性。结果冠心病组hs-cTnI水平高于非冠心病组,差异有统计学意义(P<0.01)。冠心病组患者hs-cTnI水平与冠状动脉Gensini积分呈正相关(r=0.426,P<0.05)。结论 hs-cTnI有助于冠心病的诊断,且hs-cTnI水平可能与冠状动脉的病变范围和程度有关。
出处 《国际检验医学杂志》 CAS 2012年第12期1486-1487,共2页 International Journal of Laboratory Medicine
基金 中山市科技计划项目立项课题资助项目(20113A061)
  • 相关文献

参考文献6

  • 1Apple FS,Smith SW,Pearce LA,et al.Use of the centaur TnI-Ultra assy for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome[J].Clin Chem,2008,54(4):723-728.
  • 2Gensini GG.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol,1983,51(3):606.
  • 3Kavsak PA,Newman AM,Lustig V,et al.Long-term health outcomes associated with detectable troponin I concentrations[J].Clin Chem,2007,53(2):220-227.
  • 4Eggers KM,Jaffe AS,Lind L,et al.Value of cardiac troponin Ⅰ cutoff concentration below the 99th percentile for clinical decision-making[J].Clin Chem,2009,55(1):85-92.
  • 5Apple FS,Pearce LA,Smith SW,et al.Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events[J].Clin Chem Acta,2009,55(5):930-937.
  • 6Hjortshj S,Dethlefsen C,Kristensen SR,et al.Improved assay of cardiac troponin I is more sensitive than other assays of necrosis markers[J].Scand J Clin Lab Invest,2008,68(2):130-133.

同被引文献40

  • 1张彬,赵宏胜,金爱萍,王忠勇,陆舒,王林华,黄新,姚登福,朱健华.血必净对合并全身炎症反应综合征呼衰患者炎症介质及预后的影响[J].南通大学学报(医学版),2009,29(1):42-43. 被引量:14
  • 2杜梅英.血清尿酸、血浆纤维蛋白原和抗凝血酶Ⅲ联合测定在冠心病诊断中的临床意义[J].求医问药(下半月),2013(7):162-163. 被引量:3
  • 3张亚臣,陈捷,吕宝经,荣烨之.生脉注射液对肥厚心肌超微结构和钙泵功能的影响[J].上海第二医科大学学报,2005,25(10):1022-1024. 被引量:11
  • 4Apple FS,Smith SW, Pearce LA, et al. Use of the Centaur TnI- Ultra assay for detection of myocardial infarction and adverse e- vents in patients presenting with symptoms suggestive of acute coronary syndrome [J]. Clin Chem, 2008,54 (4) : 723-728.
  • 5James S,Armstrong P,Califf R,et al. Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial[J]. Am J Med, 2003,115(3) : 178-184.
  • 6GOLD Executive Committee. Global strategy for the diagno- sis, management and prevention of chronic obstructive pul- monary disease ( Revised 2011 ) [ EB/OL]. www. goldcopd. corn.
  • 7全国肺心病协作组.慢性肺源性心脏病诊断标准[J].中华结核和呼吸系统疾病杂志,1978,1(1):56-57.
  • 8Dao Q,Krishnasway P,Kenenagra R.Utility of B-type natri- uretic peptide in diagnosis of CHF in an urgent care setting [J].AM Coil Cardiol,2001,37:379-385.
  • 9Apple FS, Murakami MM. The diagnostic utility of cardiac bio- markers in detecting myocardial infarction[J]. Clin Cornerstone, 2005,7(1) :25-30.
  • 10Le Moigne F, Beauvieux MC, Derache P, et al. Determination of myoglobin:comparative evaluation of the new automated VIDAS assay with two other immunoassays[J]. Clin Bioehem, 2002,35 (4) :255-262.

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部